Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Feng Yan

Feng Yan

Nanjing Medical University Cancer Hospital & Jiangsu Cancer Hospital, China

Title: UHRF1 is regulated by miR-9 in colorectal cancer

Biography

Biography: Feng Yan

Abstract

The UHRF1 protein is pivotal for DNA methylation and heterochromatin formation, leading to decreased expressions of tumor suppressor genes and contributing to tumorigenesis. However, the factors that modulate UHRF1 expression in colorectal cancer (CRC) remain unclear. Here we showed that, compared with corresponding normal tissues, UHRF1 was upregulated and microRNA-9 (miR-9) was downregulated in CRC tissues. The expression of UHRF1 was inversely correlated with overall survival rates of patients with CRC. Overexpression of miR-9 in CRC cell lines significantly attenuated CRC cell proliferation and promoted cell apoptosis. The expression of UHRF1 was markedly reduced in pre-miR-9 transfected CRC cells.  Using  luciferase  reporter  assay,  we  confirmed  that  miR-9  was  a  direct upstream  regulator  of  UHRF1.  Finally,  analysis  of  miR-9  and  UHRF1  levels  in human  CRC  tissues  revealed  that  expression  of  miR-9  was  inversely  correlated with UHRF1 expression. Collectively, our results offer in vitro validation of the concept  that  miR-9  could  repress  the  expression  of  UHRF1,  and  function  as  a tumor-suppressive microRNA in CRC. It may serve as a prognostic and therapeutic marker for CRC for diagnosis and a gene target for therapy. 

Speaker Presentations

Speaker PPTs Click Here